| Branched-chain amino acid therapy for spinocerebellar degeneration: a pilot clinical crossover trial. | |
| | |
MedLine Citation:
|
PMID: 10397076 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECT: The potential effects of branched-chain amino acids (BCAAs) on spinocerebellar degeneration (SCD) were explored in eleven patients. METHODS: The patients received 200 ml of BCAA-rich solution, 2 mg of thyrotropin-releasing hormone (TRH; protirelin), or a placebo daily for 7 days each in a random order. An SCD score was used to quantify the severity of symptoms. PATIENTS: Eleven patients with SCD (7 male, 4 female; mean age 60+/-11; mean disease duration 5.5 years) participated in this study. RESULTS: The mean SCD score of the eleven patients improved significantly by the BCAA treatment compared with the baseline. The conditions of five of the eleven patients (45%) were clearly improved by the BCAA treatment. All of the responders manifested predominantly cerebellar symptoms, but no prominent parkinsonian symptoms. Two patients with marked rigidity and akinesia did not respond to the treatment. CONCLUSION: We concluded that BCAAs do have a beneficial effect on functional improvement in patients with SCD, and that further large scale studies are needed. |
| | |
Authors:
|
N Mori; Y Adachi; T Takeshima; Y Kashiwaya; A Okada; K Nakashima |
Related Documents
:
|
17465866 - Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid pe... 3723796 - Masked thyroid dysfunction among elderly patients with atrial fibrillation. 8461286 - Early onset of lithium-associated hypothyroidism. 1201626 - Systolic time intervals in thyroid disease. 1960056 - Ketorolac versus dhe and metoclopramide in the treatment of migraine headaches. 11673106 - Clinical characteristics of autoimmune hepatitis with histological features of acute he... |
Publication Detail:
|
Type: Case Reports; Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Internal medicine (Tokyo, Japan) Volume: 38 ISSN: 0918-2918 ISO Abbreviation: Intern. Med. Publication Date: 1999 May |
Date Detail:
|
Created Date: 1999-08-09 Completed Date: 1999-08-09 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9204241 Medline TA: Intern Med Country: JAPAN |
Other Details:
|
Languages: eng Pagination: 401-6 Citation Subset: IM |
Affiliation:
|
Division of Neurology, Institute of Neurological Sciences, Tottori University, Faculty of Medicine, Yonago. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Amino Acids, Branched-Chain / therapeutic use* Cross-Over Studies Female Humans Male Middle Aged Pilot Projects Severity of Illness Index Single-Blind Method Spinocerebellar Degenerations / drug therapy*, physiopathology Thyrotropin-Releasing Hormone / therapeutic use Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Amino Acids, Branched-Chain; 24305-27-9/Thyrotropin-Releasing Hormone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The role of nitric oxide in bradykinin-induced dilation of coronary resistance vessels in patients w...
Next Document: Analysis of the CAG repeat number in a patient with Huntington's disease.